Medscape

New Expert Guidance on Assessing, Managing Spasticity

A new consensus guideline on the assessment and management of spasticity has been released. The American Academy of Physical Medicine and Rehabilitation (AAPM&R) guidance includes best practices, ...
Becker's ASC

Intronix Technologies’ EMG-Guided Injection System Receives FDA 510(k) Clearance

Intronix Technologies Corp., based on Ontario, Canada, has announced its Myoguide needle electromyographic-guided injection system has received FDA 510(k) clearance, according to a news release. The ...
Nasdaq

FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with Spasticity

NORTH CHICAGO, Ill., July 9, 2020 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental Biologics License ...
FierceBiotech

Allergan Inc. (AGN)'s BOTOX(R) (OnabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults

Allergan Inc. (AGN)'s BOTOX (R) (OnabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults 3/10/2010 IRVINE, Calif.-- (BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN - News ...
FiercePharma

U.S. FDA Approves BOTOX® (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults

- BOTOX® is the First and Only FDA-Approved Neurotoxin Treatment for Both Upper and Lower Limb Spasticity - DUBLIN, Jan. 22, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global ...